CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges

CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges

Hepatocellular carcinoma (HCC) ranks among the most prevalent cancers worldwide, highlighting the urgent need for improved diagnostic and therapeutic methodologies. The standard treatment regimen generally involves surgical intervention followed by systemic therapies; however, the median survival ra...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yexin Zhou, Shanshan Wei, Menghui Xu, Xinhui Wu, Wenbo Dou, Huakang Li, Zhonglin Zhang, Shuo Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Immunology
Subjects:	chimeric antigen receptor T cell hepatocellular carcinoma antigen gene therapy immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1489649/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tandem CAR-T cell therapy: recent advances and current challenges
by: Sara Gómez-Melero, et al.
Published: (2025-02-01)

Study of the suppression of a tumor growth expressing a carcinoembryonic antigen with a new high-tech drug carplasmin (CAR-T therapy) in Balb/c nude mice
by: V. K. Bozhenko, et al.
Published: (2023-04-01)

Engineered bacteria assist CAR-cell immunotherapy
by: Tianyu Shao, et al.
Published: (2025-03-01)

CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies
by: Fang Wang, et al.
Published: (2025-02-01)

Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
by: Eugenio Galli, et al.
Published: (2021-10-01)

A new therapeutic pathway in autoimmune diseases: chimeric antigen receptor T cells (CAR-T) targeting specific cell subtypes or antigen-specific B lymphocytes—a brief review
by: María Fernanda Segovia, et al.
Published: (2025-03-01)

CAR-T: from bench to bedside
by: M. О. Popova, et al.
Published: (2024-09-01)

Strategies to overcome tumour relapse caused by antigen escape after CAR T therapy
by: Yufei Lu, et al.
Published: (2025-04-01)

Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma
by: Sahand Saeidpour Masouleh, et al.
Published: (2025-05-01)

Unleashing the power of CAR-M therapy in solid tumors: a comprehensive review
by: Ahsen Morva, et al.
Published: (2025-06-01)

GPX4 is a key ferroptosis regulator orchestrating T cells and CAR-T-cells sensitivity to ferroptosis
by: Marta Kłopotowska, et al.
Published: (2025-08-01)

Targeting BCMA in multiple myeloma: designs, challenges, and future directions
by: Yi Hu, et al.
Published: (2025-02-01)

The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer
by: Hao-Yu Tang, et al.
Published: (2025-01-01)

GD2-CAR NK-92 cell activity against neuroblastoma cells is insusceptible to TIGIT knockout
by: Wiebke Jünemann, et al.
Published: (2025-05-01)

Chimeric Autoantibody Receptor- and/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases
by: Isidora Protić-Rosić, et al.
Published: (2025-05-01)

Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation
by: Catrin Heim, et al.
Published: (2024-06-01)

The clinical landscape of CAR NK cells
by: Lasse Vedel Jørgensen, et al.
Published: (2025-03-01)

CAR-T therapy: pioneering a new era in the treatment of autoimmune diseases
by: Yuanhao Wu, et al.
Published: (2025-08-01)

From lab to lifesaver: the rise of CAR T-cell therapy in oncology
by: Shriyash S. Jangavali, et al.
Published: (2025-05-01)

Does a natural killer need a CAR?
by: Kangbo Wang, et al.
Published: (2025-06-01)

CAR’TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment
by: Karin Teppert, et al.
Published: (2024-06-01)

Targeting CEA in metastatic triple negative breast cancer with image-guided radiation followed by Fab-mediated chimeric antigen receptor (CAR) T-cell therapy
by: Eric Aniogo, et al.
Published: (2024-12-01)

CAR-T Cell Therapy in Gastrointestinal Cancer, Head and Neck Cancer, and Autoimmune Diseases: Current Advances and Future Perspectives
by: Martyna Kania, et al.
Published: (2025-05-01)

Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis
by: Federica Galvagno, et al.
Published: (2024-11-01)

CAR-macrophages targets CD26 to eliminate chronic myeloid leukemia stem cells
by: Jiang Guoyun, et al.
Published: (2025-02-01)

Enhancing the physiological characteristics of chimeric antigen receptor natural killer cells by synthetic biology
by: Shuochao Ji, et al.
Published: (2025-04-01)

Efficacy and safety of CD19 combined with CD22 or CD20 chimeric antigen receptor T-cell therapy for hematological malignancies
by: Xiaoshuang Yuan, et al.
Published: (2025-05-01)

Differential susceptibility and role for senescence in CART cells based on costimulatory domains
by: Ismail Can, et al.
Published: (2025-06-01)

Co-expression of a truncated TGFβ receptor II in c-Met CAR T cells enhances antitumor activity against lung adenocarcinoma
by: Chao Su, et al.
Published: (2025-08-01)

Enhancing T cell anti-tumor efficacy with a PD1-TIGIT chimeric immune-checkpoint switch receptor
by: Jingjing Zhao, et al.
Published: (2023-12-01)

Preclinical efficacy of multi-targeting mRNA-based CAR T cell therapy in resection models of glioblastoma
by: Oula K. Dagher, et al.
Published: (2025-09-01)

Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024Keypoints
by: Bastian Engel, et al.
Published: (2025-02-01)

Expanding the Horizons of CAR-T Cell Therapy: A Review of Therapeutic Targets Across Diverse Diseases
by: Alejandrina Hernández-López, et al.
Published: (2025-01-01)

Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma
by: Jiaying Wu, et al.
Published: (2024-11-01)

Editorial: Immunotherapy resistance and advancing adaptive cell therapeutics
by: Luciana Rodrigues Carvalho Barros, et al.
Published: (2025-06-01)

Impact of corticosteroids on the efficacy of CD19/22 CAR-T cell therapy in pediatric patients with B-ALL: a single-center study
by: Jing Yang, et al.
Published: (2025-01-01)

Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma
by: Chengcheng Zhang, et al.
Published: (2023-05-01)

The impact of antibiotic use on outcomes of relapsed/refractory multiple myeloma patients treated with CAR-T therapy
by: Lingling Yin, et al.
Published: (2025-04-01)

Targeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions
by: Kaveh Hadiloo, et al.
Published: (2025-07-01)

Efficacy of MET-targeting CAR T cells against glioblastoma patient-derived xenograft models
by: Anna Qin, et al.
Published: (2025-04-01)